GGrantIndex
← Search

Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy

$218,588R44FY2018CANIH

B-Mogen Biotechnologies, Inc., Minneapolis MN

Investigators

View original record on NIH RePORTER →